FLUMIST QUADRIVALENT

This brand name is authorized in Canada, Hong Kong, Israel, United States

Active ingredients

The drug FLUMIST QUADRIVALENT contains a combination of these active pharmaceutical ingredients (APIs):

1 Influenza, inactivated, surface antigen UNII JAA7BS0D8Y - INFLUENZA A VIRUS A/HAWAII/66/2019 (H1N1) LIVE (ATTENUATED) ANTIGEN

Read about Influenza, inactivated, surface antigen

2 Influenza, inactivated, surface antigen UNII ZD4U7FM04M - INFLUENZA A VIRUS A/HONG KONG/2671/2019 (H3N2) LIVE (ATTENUATED) ANTIGEN

Read about Influenza, inactivated, surface antigen

3 Influenza, inactivated, surface antigen UNII 91E648A88W - INFLUENZA B VIRUS B/PHUKET/3073/2013 LIVE (ATTENUATED) ANTIGEN

Read about Influenza, inactivated, surface antigen

4 Influenza, inactivated, surface antigen UNII J7LDT2B7CD - INFLUENZA B VIRUS B/WASHINGTON/02/2019 LIVE (ATTENUATED) ANTIGEN

Read about Influenza, inactivated, surface antigen

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J07BB03	Influenza, live attenuated	J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines → J07BB Influenza vaccines
Discover more medicines within J07BB03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02426544
Country: HK	Department of Health Drug Office	Identifier(s): 65690
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 7584
Country: US	FDA, National Drug Code	Identifier(s): 66019-307